Stanley-Laman Group’s Aldeyra Therapeutics ALDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-98,892	Closed	-$786K	–	221
2018 Q2	$786K	Buy	98,892 +34,863	+54%	+$277K	0.18%	172
2018 Q1	$480K	Buy	+64,029	New	+$480K	0.11%	220